Status: current, Not sufficiently defined by necessary conditions definition status. Date: 30-Sep 2021. Module: SNOMED CT core module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 4592092019 | Platelet glycoprotein-IIb/IIIa receptor antagonist (disposition) | en | Fully specified name | Active | Only initial character case insensitive | SNOMED CT core module |
| 4592093012 | Platelet glycoprotein-IIb/IIIa receptor antagonist | en | Synonym | Active | Only initial character case insensitive | SNOMED CT core module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Platelet glycoprotein-IIb/IIIa receptor antagonist | Is a | Receptor antagonist | true | Inferred relationship | Existential restriction modifier | ||
| Platelet glycoprotein-IIb/IIIa receptor antagonist | Is a | Platelet aggregation inhibitor | true | Inferred relationship | Existential restriction modifier |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Substance with glycoprotein-IIb/IIIa receptor antagonist mechanism of action (substance) | Has disposition | True | Platelet glycoprotein-IIb/IIIa receptor antagonist | Inferred relationship | Existential restriction modifier | |
| Tirofiban hydrochloride monohydrate | Has disposition | True | Platelet glycoprotein-IIb/IIIa receptor antagonist | Inferred relationship | Existential restriction modifier | |
| Abciximab | Has disposition | True | Platelet glycoprotein-IIb/IIIa receptor antagonist | Inferred relationship | Existential restriction modifier | |
| Tirofiban | Has disposition | True | Platelet glycoprotein-IIb/IIIa receptor antagonist | Inferred relationship | Existential restriction modifier | |
| Eptifibatide | Has disposition | True | Platelet glycoprotein-IIb/IIIa receptor antagonist | Inferred relationship | Existential restriction modifier |
This concept is not in any reference sets
FHIR